Glycoanalytics Explained: Analysing and Designing Better Biopharmaceutical Drugs
Biotechnology is often perceived as a field exclusively for those with a background in biology.
Mastering CRO Selection: Essential Questions for CMC Analytical Development – Part 2
Cell and gene therapies have redefined what’s possible in modern medicine, but their road to market is anything but straightforward.
Mastering CRO Selection: Essential Questions for CMC Analytical Development – Part 1
Many biotech teams are sprinting to create breakthrough therapies, but often encounter the intricate and numerous challenges of CMC development.
Fighting Antimicrobial Resistance: How AI Cuts Phage Therapy Access from 6 Months to 5 Days – Part 2
What if the answer to battling antibiotic-resistant infections isn’t a new antibiotic, but harnessing viruses that have been quietly dominating bacterial populations?
From Raw Data to Actionable Insights: Unlocking the Power of Process Models
Bioprocess development has long been recognized for its complexity, requiring rigorous experimentation, considerable time, and substantial resources. Yet a shift is underway.
Fighting Antimicrobial Resistance: How AI Cuts Phage Therapy Access from 6 Months to 5 Days – Part 1
Antibiotic resistance isn’t just a looming problem. It’s a global crisis.
Mastering Quality by Design: From Product Failures to Commercial Success in Biologics CMC Development
Today we’re diving into something that could literally save your company from becoming another biotech statistic.
Mastering ADC Development: CDMO Strategies for Analytics and Scale-Up – Part 2
What happens when the charging elephant of biotech—antibody-drug conjugates (ADCs)—meets the organizational complexity of a 300-strong analytical powerhouse?
Mastering ADC Development: CDMO Strategies for Analytics and Scale-Up – Part 1
Antibody-drug conjugates (ADCs) are generating serious buzz in biotech corridors, offering a precision-guided missile against cancer while minimizing collateral damage.
Think Before You Build: Holistic Approaches to Biotech Facility Design
A common misconception among many researchers and biotech startup founders is that bioprocess development is straightforward.